2nd Due Diligence for Life Sciences

On-Demand Content | Virtual Event

RAVI KIRON, PhD, MBA Head, BioPharma External Innovation Silicon Valley Innovation Hub EMD Serono (Merck KGaA, Darmstadt, Germany) 3011 N 1st Street, San Jose, CA 95134 (650) 224-3836 Cell ravi.kiron@emdserono.com Dr. Ravi Kiron based in California, USA is an experienced pharma/biotech executive with decades of experience in discovery R&D through late-stage clinical development, intellectual property and regulatory, technology & business development, M&A, strategy and product commercialization, negotiating and executing partnerships by leveraging his extensive global business development networks in CVMD, Oncology, CNS, Wound Healing, Microbiome and Diagnostics. He was a tenure-track faculty member at Cornell University Medical College and adjunct faculty at University of Rhode Island. Dr. Kiron served in various operational & management roles at Pfizer Inc., and J&J/ALZA, in Cardiovascular R&D, Oncology clinical development (Tarceva), strategic business development and M&A (acquisition of WLA, PHA & other biotech).  Dr. Kiron has consulted for several dozen global biotech & pharma companies, founded and led multiple companies/new ventures, served as an Entrepreneur In Residence (EIR) at SRI Ventures, ShangPharma Innovation and advises company and non-profit boards. ​ Dr. Kiron earned a BS in Chemistry, MS in Microbiology from the University of Mumbai, India; a PhD in Biochemistry from the Indian Institute of Science, India and an MBA from Rensselaer Polytechnic Institute, New York, USA. Currently, Dr. Kiron is Head, BioPharma External Innovation at the Merck KGaA/EMD Serono’s Silicon Valley Innovation Hub in Menlo Park, California and is exploring cutting edge game changing technologies (such as Artificial Intelligence & Machine Learning, Microbiome, Biosensors, Longevity/Aging etc.) to have an impact on pharma/biotech product development and launches.